Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression. 2017

Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
Department of Pediatric, Immunology Division, Centre de Recherche Clinique CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Canada.

Defects in dendritic cells (DCs) development and function lead to autoimmune disorders. Autoimmune diabetes in humans and NOD mice results from a breakdown of self-tolerance, ending in T cell-mediated β-cell destruction. DCs dysfunction in NOD mice results in part from a defect in the JAK-STAT5 signaling pathway associated with the idd4 susceptibility locus. The involvement of Stat5b in DCs tolerogenic functions remains unknown. We have generated transgenic mice (NOD.CD11cStat5b-CA) expressing a constitutively active form of the Stat5b gene (Stat5b-CA) under control of CD11c promoter. All NOD.CD11cStat5b-CA mice were protected against diabetes. Protection was associated with an increased in the pool and suppressive function of Tregs, a promotion of Th2 and Tc2 immune response and a decreased percentage of CD8+ T cells. Splenic DCs of NOD.CD11cStat5b-CA mice acquired a mature phenotype, promoted and induced better conversion of CD4+CD25-Foxp3- T cells into Tregs (CD4+CD25+Foxp3+ T cells) than DCs of NOD mice. Stat5b-CA.DC-educated CD4+CD25- T cells delayed diabetes onset whereas Stat5b-CA.DC-educated Tregs blocked ongoing diabetes in 8-10 weeks old NOD recipient mice. Importantly, injection of Stat5b.CA.DC to 8-10-week old NOD mice halted diabetes progression and educated their splenocytes to loose their diabetogenic potential when transferred to NOD.SCID mice. Our work is the first to report that an active form of Stat5b restored DCs tolerogenic functions that re-educated Tregs to re-establish and to sustain long-term protective immune response against diabetes in NOD mice.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities

Related Publications

Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
September 2020, International journal of molecular sciences,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
January 2007, Immunopharmacology and immunotoxicology,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
January 2010, Cellular immunology,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
July 2011, Environmental health and preventive medicine,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
January 2013, ISRN endocrinology,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
May 2014, Journal of immunology (Baltimore, Md. : 1950),
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
December 2012, Journal of leukocyte biology,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
May 2023, Translational research : the journal of laboratory and clinical medicine,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
November 2004, European journal of immunology,
Echarki Zerif, and Aida Maalem, and Simon Gaudreau, and Chantal Guindi, and Muhammad Ramzan, and Steeve Véroneau, and Denis Gris, and Jana Stankova, and Marek Rola-Pleszczynski, and Walid Mourad, and Gilles Dupuis, and Abdelaziz Amrani
August 2012, Biochemical and biophysical research communications,
Copied contents to your clipboard!